Can EPIC Be a Low-Cost Alternative to HIPEC in Advanced Epithelial Ovarian Cancer in Resource-Constraint Settings? Experience from Tertiary Care Oncology Center.

Talluri, Sri Harsha; Ray, M D; N, Premanand; Kumar, Lalit; Garg, Rakesh; Deo, Svs

Talluri, Sri Harsha; Ray, M D; N, Premanand; Kumar, Lalit; Garg, Rakesh; Deo, Svs.

Afiliação

Talluri SH; Department of Surgical Oncology, Dr.BRAIRCH, AIIMS, New Delhi, India.
Ray MD; Department of Surgical Oncology, Dr.BRAIRCH, AIIMS, New Delhi, India.
N P; Department of Surgical Oncology, Dr.BRAIRCH, AIIMS, New Delhi, India.
Kumar L; Department of Medical Oncology, Dr.BRAIRCH, AIIMS, New Delhi, India.
Garg R; Department of Onco-anesthesia and Palliative Medicine, Dr.BRAIRCH, AIIMS, New Delhi, India.
Deo S; Department of Surgical Oncology, Dr.BRAIRCH, AIIMS, New Delhi, India.

Indian J Surg Oncol ; 14(Suppl 1): 250-256, 2023 Jun.

Article em En | MEDLINE | ID: mdl-37359930

Palavras-chave

EPIC; HIPEC; Morbidity; Ovarian cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation Idioma: En Revista: Indian J Surg Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Índia País de publicação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google